lithospermate b has been researched along with iberiotoxin in 1 studies
| Studies (lithospermate b) | Trials (lithospermate b) | Recent Studies (post-2010) (lithospermate b) | Studies (iberiotoxin) | Trials (iberiotoxin) | Recent Studies (post-2010) (iberiotoxin) |
|---|---|---|---|---|---|
| 103 | 0 | 47 | 777 | 0 | 150 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, XQ; Hu, GY; Wang, YP; Zhang, HF | 1 |
1 other study(ies) available for lithospermate b and iberiotoxin
| Article | Year |
|---|---|
Magnesium lithospermate B dilates mesenteric arteries by activating BKCa currents and contracts arteries by inhibiting K(V) currents.
Topics: Animals; Drugs, Chinese Herbal; Endothelium, Vascular; In Vitro Techniques; Large-Conductance Calcium-Activated Potassium Channel alpha Subunits; Large-Conductance Calcium-Activated Potassium Channels; Male; Mesenteric Arteries; NG-Nitroarginine Methyl Ester; Nitric Oxide; Norepinephrine; Patch-Clamp Techniques; Peptides; Potassium; Potassium Channel Blockers; Potassium Channels; Potassium Chloride; Rats; Rats, Sprague-Dawley; Tetraethylammonium; Vasoconstriction; Vasodilation | 2010 |